NASDAQ · AGRICULTURAL CHEMICALS · MID CAP
Bioceres Crop Solutions Corp. BIOX
9 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$335.1M
▼ 27.9% vs FY2023
EPS · FY24
$-0.88
Dividend / sh · FY24
—
Payout · FY24
-0%
ROE · FY24
-19.1%
Net margin · FY24
-16.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 335.1M
Revenue, FY2024 · full 9-year series below
Revenue
Net income
The company lost 17 cents on every revenue dollar this year.
Per share
USD -0.88
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
-19.1%
Return on equity, FY2024
ROE
Operating margin-0.7%
Net margin-16.5%
Return on assets-6.9%
Each USD of equity lost 19 cents this year.
Returned to shareholders
USD 998,950.00
returned in FY2024 · dividends + net buybacks
Dividends paidUSD 72,051.00
Net buybacksUSD 926,899.00
Share of profit-1.8%
Consecutive raises—
USD 72,051.00 in dividends and USD 926,899.00 in buybacks went back to shareholders in a year without profit.
Growth
+14.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+0.0%
+14.1%
Returned to shareholders
+100.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2024
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 763.6M
total assets, end of FY2024
Total assetsUSD 763.6M
EquityUSD 265.4M
CashUSD 32.7M
Current ratio0.91×
Equity funds 35% of total assets.
History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.3
0.5
0.4
0.3
0.2
0.2
0.2
0.1
0.0
Operating income $B
−0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
·
·
·
·
·
·
·
·
·
Income tax $B
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
Net income $B
−0.1
0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.88
0.07
0.30
−0.17
−0.18
0.09
−0.60
−0.39
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
Payout %
−0
4
2
·
·
·
·
·
−0
ROE %
−19.1
1.4
8.8
−7.4
−12.1
7.2
−60.2
−80.5
·
Shares out B
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
34 of 34
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed